Human Hepatic Flavin-Containing Monooxygenases 1 (FMO1) and 3 (FMO3) Developmental Expression

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4350 · Cited by 53,218

Measurement of protein using bicinchoninic acid

Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., & Klenk, D. C. (1985) · Analytical Biochemistry · doi:10.1016/0003-2697(85)90442-7 · Cited by 18,482

Expression of CYP3A in the Human Liver — Evidence that the Shift between CYP3A7 and CYP3A4 Occurs Immediately After Birth

Lacroix, D. A., Sonnier, M., Moncion, A., Chéron, G., & Cresteil, T. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00625.x · Cited by 537

Glucuronidation in Humans

de Wildt, S. N., KEARNS, G., Leeder, J. S., & van den Anker, J. N. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199936060-00005 · Cited by 392

Isoform specificity of trimethylamine N-oxygenation by human flavin-containing monooxygenase (FMO) and P450 enzymes

Lang, D., Yeung, C., Peter, R., Ibarra, C., Gasser, R., Itagaki, K., Philpot, R., & Rettie, A. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00218-4 · Cited by 303

Missense mutation in flavin-containing mono-oxygenase 3 gene, FMO3, underlies fish-odour syndrome

Dolphin, C. T., Janmohamed, A., Smith, R. L., Shephard, E. A., & Phillips, L. R. (1997) · Nature Genetics · doi:10.1038/ng1297-491 · Cited by 284

Effects of Freezing, Thawing, and Storing Human Liver Microsomes on Cytochrome P450 Activity

Pearce, R. E., McIntyre, C. J., Madan, A., Sanzgiri, U. Y., Draper, A. J., Bullock, P. L., Cook, D. C., Burton, L. A., Latham, J., Nevins, C., et al. (1996) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1996.0294 · Cited by 253

Recent Studies on the Structure and Function of Multisubstrate Flavin-Containing Monooxygenases

Ziegler, D. M. (1993) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.33.040193.001143 · Cited by 248

Microsomal Flavin-Containing Monooxygenase: Oxygenation of Nucleophilic Nitrogen and Sulfur Compounds

Ziegler, D. M. (1980) · Elsevier eBooks · doi:10.1016/b978-0-12-380001-5.50015-3 · Cited by 234

Prenatal and Postnatal Expression of Glutathione Transferase ζ 1 in Human Liver and the Roles of Haplotype and Subject Age in Determining Activity with Dichloroacetate

Li, W., Gu, Y., James, M. O., Hines, R. N., Simpson, P. M., Langaee, T. Y., & Stacpoole, P. W. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.041533 · Cited by 31

Flavin-containing monooxygenase 3 (FMO3) role in busulphan metabolic pathway

Serafi, I. E., Terelius, Y., Abedi‐Valugerdi, M., Naughton, S., Saghafian, M., Moshfegh, A., Mattsson, J., Potácová, Z., & Hassan, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187294 · Cited by 30

Tolerance to acetaminophen hepatotoxicity in the mouse model of autoprotection is associated with induction of flavin-containing monooxygenase-3 (FMO3) in hepatocytes.

Rudraiah, S., Rohrer, P. R., Gurevich, I., Goedken, M. J., Rasmussen, T., Hines, R., & Manautou, J. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kfu124 · Cited by 29

Cytostatic drugs in infants: A review on pharmacokinetic data in infants

van den Berg, H., van den Anker, J. N., & Beijnen, J. H. (2011) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2011.03.005 · Cited by 30

Quantification of Flavin-containing Monooxygenases 1, 3, and 5 in Human Liver Microsomes by UPLC-MRM-Based Targeted Quantitative Proteomics and Its Application to the Study of Ontogeny

Chen, Y., Zane, N. R., Thakker, D. R., & Wang, M. Z. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.067538 · Cited by 30

Genome-wide association identifies genetic variants associated with lentiform nucleus volume in N = 1345 young and elderly subjects

Initiative, T. A. D. N., Hibar, D. P., Stein, J. L., Ryles, A. B., Omid Kohannim, A., Jahanshad, N., Medland, S. E., Hansell, N. K., McMahon, K. L., de Zubicaray, G. I., et al. (2012) · Brain Imaging and Behavior · doi:10.1007/s11682-012-9199-7 · Cited by 29

Role of reactive metabolites in the circulation in extrahepatic toxicity

Irving, R. M., & Elfarra, A. A. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.695347 · Cited by 29

Ontogeny of Drug-Metabolizing Enzymes

Thakur, A., Parvez, M. M., Leeder, J. S., & Prasad, B. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1554-6_18 · Cited by 28

Molecular and functional characterization of flavin-containing monooxygenases in pigs, dogs, and cats

Uno, Y., Shimizu, M., Ogawa, Y., Makiguchi, M., Kawaguchi, H., Yamato, O., Ishizuka, M., & Yamazaki, H. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115125 · Cited by 28

Differential regulation of human hepatic flavin containing monooxygenase 3 (FMO3) by CCAAT/enhancer-binding protein β (C/EBPβ) liver inhibitory and liver activating proteins

Klick, D. E., Shadley, J. D., & Hines, R. N. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.05.002 · Cited by 28

Plasma Trimethylamine N-Oxide and Its Precursors: Population Epidemiology, Parent–Child Concordance, and Associations with Reported Dietary Intake in 11- to 12-Year-Old Children and Their Parents

Andraos, S., Lange, K., Clifford, S. A., Jones, B., Thorstensen, E. B., Kerr, J. A., Wake, M. A., Saffery, R., Burgner, D. P., & O'Sullivan, J. M. (2020) · Current Developments in Nutrition · doi:10.1093/cdn/nzaa103 · Cited by 29

Expression Patterns of Organic Anion Transporting Polypeptides 1B1 and 1B3 Protein in Human Pediatric Liver

Thomson, M., Hines, R. N., Schuetz, E. G., & Meibohm, B. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.069252 · Cited by 27

Relationships between flavin‐containing mono‐oxygenase 3 ( FMO3 ) genotype and trimethylaminuria phenotype in a J apanese population

Shimizu, M., Allerston, C. K., Shephard, E. A., Yamazaki, H., & Phillips, I. R. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12240 · Cited by 25

Variants in the flavin-containing monooxygenase 3 (FMO3) gene responsible for trimethylaminuria in a Japanese population

Shimizu, M., Kobayashi, Y., Hayashi, S., Aoki, Y., & Yamazaki, H. (2012) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2012.06.014 · Cited by 25

Trio‐binned genomes of the woodrats Neotoma bryanti and Neotoma lepida reveal novel gene islands and rapid copy number evolution of xenobiotic metabolizing genes

Greenhalgh, R., Holding, M. L., Orr, T. J., Henderson, J., Parchman, T. L., Matocq, M. D., Shapiro, M. D., & Dearing, M. D. (2022) · Molecular Ecology Resources · doi:10.1111/1755-0998.13650 · Cited by 26

Identification of a novel enzyme and the regulation of key enzymes in mammalian taurine synthesis

Miyazaki, T. (2023) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2023.11.003 · Cited by 24

Deletion of the mouse Fmo1 gene results in enhanced pharmacological behavioural responses to imipramine

Hernandez, D., Janmohamed, A., Chandan, P., Omar, B. A., Phillips, I. R., & Shephard, E. A. (2009) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328328d507 · Cited by 23

Developmental Pharmacokinetics of Antibiotics Used in Neonatal ICU: Focus on Preterm Infants

Butranova, O. I., Ushkalova, E. A., Zyryanov, S. K., & Станиславович, Ч. М. (2023) · Biomedicines · doi:10.3390/biomedicines11030940 · Cited by 24

Electro-catalysis by immobilised human flavin-containing monooxygenase isoform 3 (hFMO3)

Castrignanò, S., Sadeghi, S. J., & Gilardi, G. (2010) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-010-4014-z · Cited by 23

Effect of pregnancy on a measure of FMO3 activity

Hukkanen, J., Dempsey, D. A., Jacob, P., & Benowitz, N. L. (2005) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2005.02406.x · Cited by 23

Mechanisms Regulating Human FMO3 Transcription

Klick, D. E., & Hines, R. N. (2007) · Drug Metabolism Reviews · doi:10.1080/03602530701498612 · Cited by 23

Physiologically Based Pharmacokinetic Modeling in Neonates: Current Status and Future Perspectives

Zhang, W., Zhang, Q., Cao, Z., Zheng, L., & Hu, W. M. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15122765 · Cited by 22

Developmental Changes of Aldehyde Oxidase Activity and Protein Expression in Human Liver Cytosol

Tayama, Y., Sugihara, K., Sanoh, S., Miyake, K., Kitamura, S., & Ohta, S. (2012) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-11-nt-124 · Cited by 22

FMO3 allelic variants in Sicilian and Sardinian populations: Trimethylaminuria and absence of fish-like body odor

D’Angelo, R., Esposito, T., Calabrò, M., Rinaldi, C., Robledo, R., Varriale, B., & Sidoti, A. (2012) · Gene · doi:10.1016/j.gene.2012.12.047 · Cited by 21

Genetics and Susceptibility to Toxic Chemicals: Do You (or Should You) Know Your Genetic Profile?

Lash, L. H., Hines, R. N., Gonzalez, F. J., Zacharewski, T. R., & Rothstein, M. A. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.039925 · Cited by 20

Regulatory Polymorphisms and their Contribution to Interindividual Differences in the Expression of Enzymes Influencing Drug and Toxicant Disposition

Hines, R. N., Koukouritaki, S. B., Poch, M. T., & Stephens, M. C. (2008) · Drug Metabolism Reviews · doi:10.1080/03602530801952682 · Cited by 21

Endogenous Roles of Mammalian Flavin-Containing Monooxygenases

Phillips, I. R., & Shephard, E. A. (2019) · Catalysts · doi:10.3390/catal9121001 · Cited by 19

Flavin-containing monooxygenase S-oxygenation of a series of thioureas and thiones

Henderson, M. C., Siddens, L. K., Krueger, S. K., Stevens, J. F., Kedzie, K. M., Fang, W., Heidelbaugh, T. M., Nguyen, P., Chow, K., Garst, M. E., et al. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.04.002 · Cited by 19

Clinical utility gene card for: Trimethylaminuria

Shephard, E. A., Treacy, E. P., & Phillips, I. R. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2011.214 · Cited by 19

Physiologically Based Pharmacokinetics Modeling in the Neonatal Population—Current Advances, Challenges, and Opportunities

Dinh, J., Johnson, T. N., Grimstein, M., & Lewis, T. R. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15112579 · Cited by 19

The potential of knockout mouse lines in defining the role of flavin-containing monooxygenases in drug metabolism

Shephard, E. A., & Phillips, I. R. (2010) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2010.503705 · Cited by 18

Trimethylaminuria (fish odor syndrome): Genotype characterization among Portuguese patients

Ferreira, F. M. B., Esteves, S., Almeida, L. S., Gaspar, A. M. C., da Costa, C. D., Janeiro, P. C. R. B., Bandeira, A., Martins, E., Teles, E. L., Garcia, P., et al. (2013) · Gene · doi:10.1016/j.gene.2013.05.025 · Cited by 18

No population left behind: Improving paediatric drug safety using informatics and systems biology

Giangreco, N., Elias, J. E., & Tatonetti, N. P. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14705 · Cited by 17

Pharmacogenomics and the Future of Drug Therapy

Hines, R. N., & McCarver, D. G. (2006) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2006.05.008 · Cited by 17

Expression and Characterization of Functional Dog Flavin-Containing Monooxygenase 1

Stevens, J. C., Melton, R. J., Zaya, M. J., & Engel, L. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.2.271 · Cited by 17

Cyclic Conversion of the Novel Src Kinase Inhibitor [7-(2,6-Dichloro-phenyl)-5-methyl-benzo[1,2,4]triazin-3-yl]-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-amine (TG100435) and Its N-Oxide Metabolite by Flavin-Containing Monoxygenases and Cytochrome P450 Reductase

Kousba, A. A., Söll, R., Yee, S., & Martin, M. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.017384 · Cited by 17

Fish odor syndrome (trimethylaminuria) supporting the possible FMO3 down expression in childhood: a case report

D’Angelo, R., Scimone, C., Esposito, T., Bruschetta, D., Rinaldi, C., Ruggeri, A., & Sidoti, A. (2014) · Journal of Medical Case Reports · doi:10.1186/1752-1947-8-328 · Cited by 16

Genetic variants of flavin-containing monooxygenase 3 (FMO3) in Japanese subjects identified by phenotyping for trimethylaminuria and found in a database of genome resources

Shimizu, M., Koibuchi, N., Mizugaki, A., Hishinuma, E., Saito, S., Hiratsuka, M., & Yamazaki, H. (2021) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2021.100387 · Cited by 16

Role of farnesoid X receptor in establishment of ontogeny of phase-I drug metabolizing enzyme genes in mouse liver

Peng, L., Piekos, S. C., Guo, G. L., & Zhong, X. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.07.015 · Cited by 16

A physiological role for flavin-containing monooxygenase (FMO3) in humans?

Mitchell, S. C., & Smith, R. L. (2010) · Xenobiotica · doi:10.3109/00498251003702753 · Cited by 16

Estimation of FMO3 Ontogeny by Mechanistic Population Pharmacokinetic Modelling of Risdiplam and Its Impact on Drug–Drug Interactions in Children

Cleary, Y., Kletzl, H., Grimsey, P., Heinig, K., Ogungbenro, K., Silber-Baumann, H., Frey, N., Aarons, L., Galetin, A., & Gertz, M. (2023) · Clinical Pharmacokinetics · doi:10.1007/s40262-023-01241-7 · Cited by 13

Non-P450 Mediated Oxidative Metabolism of Xenobiotics

Lang, D. H., & Kalgutkar, A. S. S. (2003) · Informa Healthcare eBooks · doi:10.1201/9781420028485.ch14 · Cited by 15

A variety of cytochrome P450 enzymes and flavin-containing monooxygenases in dogs and pigs commonly used as preclinical animal models

Uno, Y., Shimizu, M., & Yamazaki, H. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116124 · Cited by 14

Complex Mechanism Underlying Transcriptional Control of the Haplotyped Flavin-containing Monooxygenase 3 (FMO3) Gene in Japanese: Different Regulation between Mutations in 5′-Upstream Distal Region and Common Element in Proximal Region

Shimizu, M., Murayama, N., Nagashima, S., Fujieda, M., & Yamazaki, H. (2008) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.23.54 · Cited by 14

Transient Massive Trimethylaminuria Associated with Food Protein–Induced Enterocolitis Syndrome

Miller, N. B., Beigelman, A., Utterson, E. C., & Shinawi, M. S. (2013) · JIMD Reports · doi:10.1007/8904_2013_238 · Cited by 14

In Vivo Metabolism of l-Methionine in Mice: Evidence for Stereoselective Formation of Methionine-d-Sulfoxide and Quantitation of Other Major Metabolites

Dever, J. T., & Elfarra, A. A. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.012104 · Cited by 14

Purification and Characterization of Flavin-Containing Monooxygenase Isoform 3 from Rat Kidney Microsomes

Novick, R. M., & Elfarra, A. A. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.021436 · Cited by 13

Trimethylamine—The Extracorporeal Envoy

Mitchell, S. C., & Smith, R. L. (2016) · Chemical Senses · doi:10.1093/chemse/bjw001 · Cited by 14

The Impact of Age and Genetics on Naltrexone Biotransformation

Stancil, S. L., Nolte, W. M., Pearce, R. E., Staggs, V. S., & Leeder, J. S. (2021) · Drug Metabolism and Disposition · doi:10.1124/dmd.121.000646 · Cited by 13

Flavin-Containing Monooxygenase 3 Reduces Endoplasmic Reticulum Stress in Lipid-Treated Hepatocytes

Liao, B. M., McManus, S. A., Hughes, W. E., & Schmitz‐Peiffer, C. (2016) · Molecular Endocrinology · doi:10.1210/me.2015-1217 · Cited by 14

Potential implications of DMET ontogeny on the disposition of commonly prescribed drugs in neonatal and pediatric intensive care units

Naji‐Talakar, S., Sharma, S., Martin, L. A., Barnhart, D., & Prasad, B. (2020) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2021.1858051 · Cited by 12

Deficiency of flavin-containing monooxygenase 3 protects kidney function after ischemia–reperfusion in mice

Wang, J., Wang, W., Zhang, J., Xiao, F., Li, Z., Xu, P., Wang, H., Du, H., Liu, S., Li, H., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-06718-0 · Cited by 12

An Investigation into the Prediction of the Plasma Concentration-Time Profile and Its Interindividual Variability for a Range of Flavin-Containing Monooxygenase Substrates Using a Physiologically Based Pharmacokinetic Modeling Approach

Reddy, V. P., Jones, B., Colclough, N., Srivastava, A., Wilson, J., & Li, D. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.118.080648 · Cited by 12

Physiologically Based Pharmacokinetic Modeling Approach to Predict Drug‐Drug Interactions With Ethionamide Involving Impact of Genetic Polymorphism on FMO3

Phương, N. T. T., Parvez, M. M., Kim, M. J., Yoo, S. E., Ahn, S., Ghim, J., & Shin, J. (2019) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1378 · Cited by 12

Human pharmacokinetic profiling of the dipeptidyl peptidase‐IV inhibitor teneligliptin using physiologically based pharmacokinetic modeling

Nakamaru, Y., Emoto, C., Shimizu, M., & Yamazaki, H. (2014) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.1928 · Cited by 11

Predicted Contributions of Flavin-containing Monooxygenases to the N-oxygenation of Drug Candidates Based on their Estimated Base Dissociation Constants

Taniguchi-Takizawa, T., Kato, H., Shimizu, M., & Yamazaki, H. (2020) · Current Drug Metabolism · doi:10.2174/1389200221666201207195758 · Cited by 11

The origin of trimethylamine- N-oxide (TMAO) and its role in development of atherosclerosis

He, Z., & Chen, Z. (2018) · Journal of Food Bioactives · doi:10.31665/jfb.2018.2138 · Cited by 12

Development of a Physiologically Based Pharmacokinetic Model of Ethionamide in the Pediatric Population by Integrating Flavin‐Containing Monooxygenase 3 Maturational Changes Over Time

Phương, N. T. T., Parvez, M. M., Kim, M. J., Lee, J. H., Ahn, S., Ghim, J., & Shin, J. (2018) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1133 · Cited by 10

Determination General and reproductive toxicology

(2003) · Informa Healthcare eBooks · doi:10.1201/9781420022926.ch5 · Cited by 10

A Time-Embedding Network Models the Ontogeny of 23 Hepatic Drug Metabolizing Enzymes

Matlock, M. K., Tambe, A., Elliott-Higgins, J., Hines, R. N., Miller, G. P., & Swamidass, S. J. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00223 · Cited by 10

Enzymatically Produced Trimethylamine N-Oxide: Conserving It or Eliminating It

Catucci, G., Querio, G., Sadeghi, S. J., Gilardi, G., & Levi, R. C. (2019) · Catalysts · doi:10.3390/catal9121028 · Cited by 10

Species Differences in the Oxidative Desulfurization of a Thiouracil-Based Irreversible Myeloperoxidase Inactivator by Flavin-Containing Monooxygenase Enzymes

Eng, H. F., Sharma, R., Wolford, A. C., Di, L., Ruggeri, R. B., Buckbinder, L., Conn, E. L., Dalvie, D., & Kalgutkar, A. S. S. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.070185 · Cited by 9

The genetic and biochemical basis of trimethylaminuria in an Irish cohort

Doyle, S., O’Byrne, J. J., Nesbitt, M., Murphy, D. N., Abidin, Z., Byrne, N., Pastores, G. M., Kirk, R., & Treacy, E. P. (2019) · JIMD Reports · doi:10.1002/jmd2.12028 · Cited by 9

Expression and Characterization of Functional Dog Flavin-Containing Monooxygenase 3

Lickteig, A. J., Riley, R., Melton, R. J., Reitz, B. A., Fischer, H., & Stevens, J. C. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.027714 · Cited by 9

Marmoset Flavin-Containing Monooxygenase 3 in the Liver Is a Major Benzydamine and Sulindac Sulfide Oxygenase

Uehara, S., Shimizu, M., Uno, Y., Inoue, T., Sasaki, E., & Yamazaki, H. (2017) · Drug Metabolism and Disposition · doi:10.1124/dmd.117.075184 · Cited by 9

N-Oxygenation of Oxycodone and Retro-reduction of Oxycodone N-Oxide

Cashman, J. R., Gohdes, M. A., de Kater, A., & Schoenhard, G. L. (2019) · Drug Metabolism and Disposition · doi:10.1124/dmd.119.089300 · Cited by 8

The Impact of Scaling Factor Variability on Risk-Relevant Pharmacokinetic Outcomes in Children: A Case Study Using Bromodichloromethane (BDCM)

Kenyon, E. M., Lipscomb, J. C., Pegram, R. A., George, B. J., & Hines, R. N. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfy236 · Cited by 8

A novel mutation in the flavin-containing monooxygenase 3 gene (FMO3) of a Norwegian family causes trimethylaminuria

Allerston, C. K., Høberg‐Vetti, H., Houge, G., Phillips, I. R., & Shephard, E. A. (2009) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2009.06.002 · Cited by 8

Regulation of Xenobiotic Metabolism in the Liver

Cui, J. Y., & Li, C. Y. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64087-4 · Cited by 7

Hepatic Flavin-Containing Monooxygenase 3 Enzyme Suppressed by Type 1 Allergy-Produced Nitric Oxide

Tanino, T., Bando, T., Komada, A., Nojiri, Y., Okada, Y., Ueda, Y., & Sakurai, E. (2017) · Drug Metabolism and Disposition · doi:10.1124/dmd.117.076570 · Cited by 7

Multi-omic network-based interrogation of rat liver metabolism following gastric bypass surgery featuring SWATH proteomics

Sridharan, G. V., D'Alessandro, M. R., Bale, S. S., Bhagat, V. H., Gagnon, H., Asara, J. M., Uygun, K., Yarmush, M. L., & Saeidi, N. (2017) · TECHNOLOGY · doi:10.1142/s233954781750008x · Cited by 7

Principles of Drug Metabolism 3: Enzymes and Tissues

Totah, R. A., & Rettie, A. E. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00121-8 · Cited by 7

Population Physiologically‐Based Pharmacokinetic Modeling to Determine Ontogeny: A Quantitative Clinical Pharmacology Example in Pediatric Rare Disease

Cleary, Y., Prasad, B., Ogungbenro, K., Gertz, M., & Galetin, A. (2026) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.70174 · Cited by 6

Exploring Trimethylaminuria: Genetics and Molecular Mechanisms, Epidemiology, and Emerging Therapeutic Strategies

Sidoti, A., D’Angelo, R., Castagnetti, A., Viciani, E., Scimone, C., Alibrandi, S., & Giannini, G. (2024) · Biology · doi:10.3390/biology13120961 · Cited by 6

Variability in intestinal drug metabolizing enzymes and transporters in Crohn's disease and potential impact on oral drug absorption

Alrubia, S., Achour, B., Al‐Majdoub, Z. M., Rostami‐Hodjegan, A., & Barber, J. (2025) · British Journal of Clinical Pharmacology · doi:10.1002/bcp.70019 · Cited by 6

In vivo drug interactions of itopride and trimethylamine mediated by flavin-containing monooxygenase 3 in humanized-liver mice

Shimizu, M., Uehara, S., Suemizu, H., & Yamazaki, H. (2020) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2020.11.004 · Cited by 5

Morphological and molecular evolution of hadal amphipod’s eggs provides insights into embryogenesis under high hydrostatic pressure

Li, W., Wang, F., Jiang, S., Pan, B., Liu, Q., & Xu, Q. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.987409 · Cited by 5

Molecular and functional characterization of flavin-containing monooxygenases (FMO1–6) in tree shrews

Uno, Y., Makiguchi, M., Ushirozako, G., Tsukiyama–Kohara, K., Shimizu, M., & Yamazaki, H. (2024) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2024.109835 · Cited by 5

Trimethylaminuria

Sabir, N., Jones, E. A., & Padmakumar, B. (2016) · BMJ Case Reports · doi:10.1136/bcr-2015-213742 · Cited by 5

IL-6 Affects Liver Metabolic Abnormalities Caused by Silicon Exposure by Regulating the PKC/YY1 Signaling Pathway

Zhao, H., Tao, H., Gao, J., Wang, J., Hui, G., Zhu, Y., Wang, J., Ding, X., & Dai, Y. (2025) · Genes · doi:10.3390/genes16040456 · Cited by 4

Taurine supplementation at the crossroads of metabolism, inflammation and aging: mechanistic and nutritional perspectives

Beine, B. J., Castellano, M., Fiamoncini, J., & Hiller, K. (2026) · Food & Function · doi:10.1039/d6fo01808d · Cited by 4

Chapter 17: Pharmacological Considerations of Antitubercular Agents in Children

Goldman, J. L., Kearns, G. L., & Abdel‐Rahman, S. M. (2011) · Progress in respiratory research/Progress in research in emphysema and chronic bronchitis/Progress in respiration research · doi:10.1159/000324904 · Cited by 4

Quinuclidine N-Oxygenation Mediated by Flavin-Containing Monooxygenases 1 and 3 in Kidney and Liver Microsomes from Humans, Monkeys, Dogs, and Pigs

Shimizu, M., Makiguchi, M., Uno, Y., & Yamazaki, H. (2024) · Drug Metabolism and Disposition · doi:10.1124/dmd.124.001728 · Cited by 4

Functional Development of the Liver

Suchy, F. J. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511547409.004 · Cited by 4

Individual Differences of Drug-metabolizing Enzymes as Determinants for the Metabolic Fate of Chemicals-A Study of Trimethylamine and Flavin-containing Monooxygenase 3-

Shimizu, M. (2009) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.129.1351 · Cited by 4

Trimethylaminuria

Wevers, R. A., & Engelke, U. F. H. (2008) · Springer eBooks · doi:10.1007/978-3-540-76698-8_34 · Cited by 4

Developmental and Reproductive Toxicity Risk Assessment for Environmental Agents

Euling, S. Y., Kimmel, C. A., & Kimmel, G. L. (2005) · Informa Healthcare eBooks · doi:10.1201/9781420040548.ch21 · Cited by 3

Functional assessment of rat pulmonary flavin-containing monooxygenase activity

Yilmaz, Y., Williams, G., Manevski, N., Walles, M., Krähenbühl, S., & Camenisch, G. (2018) · Xenobiotica · doi:10.1080/00498254.2018.1469804 · Cited by 3

Trimethylamine N-oxygenation in cynomolgus macaques genotyped for flavin-containing monooxygenase 3 (FMO3)

Shimizu, M., Uno, Y., Utoh, M., & Yamazaki, H. (2020) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2020.07.001 · Cited by 3

Mulberry Leaf and Radix Astragali Regulates Differentially Expressed Genes and Proteins in the Streptozotocin-Induced Diabetic Mice Liver

Zhang, S., Ge, Q., Chen, L., & Chen, K. (2021) · Processes · doi:10.3390/pr9111898 · Cited by 4

Flavin‐Containing Monooxygenase: The Role of Flavin‐Containing Monooxgenase in Lead Design and Selection

Cashman, J. R. (2012) · Wiley eBooks · doi:10.1002/9780470921920.edm010 · Cited by 3

Effects of Liver Disease on Drug Metabolism in Humans

Tan, H., & Schiano, T. D. (2012) · Wiley eBooks · doi:10.1002/9780470921920.edm125 · Cited by 3

Role of Bioactivation Reactions in Chemically Induced Nephrotoxicity

Lash, L. H. (2008) · doi:10.1002/9780470439265.ch26 · Cited by 3

Age‐Dependent Expression of Human Drug‐Metabolizing Enzymes

Hines, R. (2012) · Encyclopedia of Drug Metabolism and Interactions · doi:10.1002/9780470921920.edm085 · Cited by 4

Hepatotoxicity assessment of innovative nutritional supplements based on olive-oil formulations enriched with natural antioxidants

Prodromou, S. I., Chatzopoulou, F. M., Saiti, A., Giannopoulos‐Dimitriou, A., Koudoura, L. A., Pantazaki, Α. A., Chatzidimitriou, D., Vasiliou, V., & Vizirianakis, I. S. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1388492 · Cited by 2

Transport and Metabolism of Xenobiotics in the Urban Ecosystem

Paul, S., Ghosh, U., & Saha, M. S. (2023) · Springer eBooks · doi:10.1007/978-3-031-35775-6_4 · Cited by 3

Triethylamine N-oxygenation mediated by liver and kidney microsomes and recombinant flavin-containing monooxygenase 3 (FMO3) and FMO1 proteins from humans, monkeys, pigs, and dogs

Shimizu, M., Nii, A., Uno, Y., & Yamazaki, H. (2025) · Drug Metabolism and Disposition · doi:10.1016/j.dmd.2025.100140 · Cited by 2

Trimethylaminuria and Dimethylglycine Dehydrogenase Deficiency

Walker, V., & Wevers, R. A. (2011) · Springer eBooks · doi:10.1007/978-3-642-15720-2_31 · Cited by 2

Flavin-containing monooxygenase 3 gene polymorphisms in Turkish population

Özhan, G., Topal, P., & Alpertunga, B. (2012) · Toxicology Mechanisms and Methods · doi:10.3109/15376516.2012.672481 · Cited by 2

Therapeutic product disposition in at-risk populations

Foster, B. C. (2009) · Radiation Protection Dosimetry · doi:10.1093/rpd/ncp071 · Cited by 2

Differential developmental and tissue-specific regulation of expression of the genes encoding three members of the flavin-containing monooxygenase family of man, FMO1, FM03 and FM04

Dolphin, C., Cullingford, T., Shephard, E., Smith, R., & Phillips, I. (1996) · UCL Discovery (University College London)

Differential Developmental and Tissue‐Specific Regulation of Expression of the Genes Encoding Three Members of the Flavin‐Containing Monooxygenase Family of Man, FMO1, FMO3 and FMO4

Dolphin, C. T., Cullingford, T. E., Shcphard, E. A., Smith, R. L., & Phillips, I. R. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.00683.x · Cited by 152

Developmental and tissue-specific expression of human flavin-containing monooxygenases 1 and 3

Hines, R. N. (2006) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2.1.41 · Cited by 42

Developmental regulation of flavin-containing monooxygenase form 1 in the liver and kidney of fetal and neonatal rabbits

Larsen-Su, S. A., Krueger, S. K., Yueh, M., Pereira, C. B., & Williams, D. E. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)00872-9 · Cited by 3

Physiological factors affecting protein expression of flavin-containing monooxygenases 1, 3 and 5

Cherrington, N. J., Cao, Y., Cherrington, J. W., Rose, R. L., & Hodgson, E. (1998) · Xenobiotica · doi:10.1080/004982598239254 · Cited by 82